ATLAS Lægemiddeludvidende koronarstentsystem Kobolt-krom
A kobolt-krom levering af koronar stent holdbar radial styrke og fremragende sporbarhed, velegnet til kompleks eller forkalket koronarlæsioner og samtidig sikre minimal rekyl.
Den ATLAS Drug Eluting Coronary Stent System is a next-generation cobalt-chromium (CoCr) stent platform coated with a sirolimus formulation (1 µg/mm²) designed to reduce restenosis in patients with coronary artery disease. By combining advanced laser-cutting technology and a clinically proven antiproliferative drug, the ATLAS system delivers durable vessel patency and a high safety profile in both de novo lesions and in-stent restenosis scenarios.
Cobalt-Chromium Alloy (L605) Construction
- Ensures exceptional strength-to-thickness ratio, enabling thinner struts without compromising radial force.
- Exhibits excellent corrosion resistance and biocompatibility for a stable healing environment.
Laser-Cut Stent Design
- Precision machining yields consistent strut geometry, promoting uniform drug distribution and an even healing surface along the vessel wall.
- Enhances stent deliverability, allowing smooth passage through calcified or tortuous coronary segments.
Sirolimus Elution Profile
- 1 µg/mm² of sirolimus is coated onto the stent’s surface, ensuring a sustained, controlled release that minimizes in-stent neointimal growth.
- Controlled drug release aids in rapid endothelialization, lowering the risk of late stent thrombosis.
Radiopaque Pt-Ir Markers
- Platinum-iridium markers at stent edges enable precise visibility under fluoroscopy.
- Facilitates accurate positioning during percutaneous coronary intervention (PCI) procedures.
High-Pressure Capability
interventional cardiologists flexibility to optimize stent expansion based on lesion complexity.
Specifikation | Detalje / værdi |
Produktets navn | Atlas Coronary Stent (Cobalt Chromium) |
Stent Type | Balloon-Expandable Coronary Stent |
Materiale | Cobalt-Chromium Alloy |
Strut Thickness | ~80 µm (typical) |
Design | Open-cell or hybrid-cell architecture (depending on exact model) |
Nominal Pressure (NP) | 9–10 atm |
Rated Burst Pressure (RBP) | ~14–16 atm |
Stent Delivery System | Rapid-Exchange (RX) or Over-the-Wire (OTW), typically 140 cm shaft length |
Kompatibilitet med guidewire | 0.014” |
Stent Surface | Bare-metal or optional drug-eluting polymer (if applicable) |
Indikationer | Coronary artery lesion scaffolding, single or multivessel disease, potential usage in small/medium/large vessels |
Kontraindikationer | Lesions unsuited for balloon-expandable stent therapy (e.g., severely calcified, left main trunk, etc.), or as per physician discretion |
Sterilitet | Steril (ethylenoxid) |
Engangsbrug | Ja |
Holdbarhed | 2–3 years (depending on final packaging and polymer, if any) |
Driftstemperatur | Recommended 15–25 °C for storage |
Detaljeret størrelsesbaseret bestilling og produktkoder
Stent Diameter (mm) | Stent Length (mm) | Nominal Pressure (atm) | RBP (atm) | Produktkode |
2.00 | 8 | 9 | 14 | ATLS-CC-2.00x08 |
2.00 | 12 | 9 | 14 | ATLS-CC-2.00x12 |
2.00 | 15 | 9 | 14 | ATLS-CC-2.00x15 |
2.00 | 18 | 10 | 16 | ATLS-CC-2.00x18 |
2.00 | 24 | 10 | 16 | ATLS-CC-2.00x24 |
2.00 | 28 | 10 | 16 | ATLS-CC-2.00x28 |
2.00 | 32 | 10 | 16 | ATLS-CC-2.00x32 |
2.00 | 38 | 10 | 16 | ATLS-CC-2.00x38 |
2.25 | 8 | 9 | 14 | ATLS-CC-2.25x08 |
2.25 | 12 | 9 | 14 | ATLS-CC-2.25x12 |
2.25 | 15 | 9 | 14 | ATLS-CC-2.25x15 |
2.25 | 18 | 10 | 16 | ATLS-CC-2.25x18 |
2.25 | 24 | 10 | 16 | ATLS-CC-2.25x24 |
2.25 | 28 | 10 | 16 | ATLS-CC-2.25x28 |
2.25 | 32 | 10 | 16 | ATLS-CC-2.25x32 |
2.25 | 38 | 10 | 16 | ATLS-CC-2.25x38 |
2.50 | 8 | 9 | 14 | ATLS-CC-2.50x08 |
2.50 | 12 | 9 | 14 | ATLS-CC-2.50x12 |
2.50 | 15 | 9 | 14 | ATLS-CC-2.50x15 |
2.50 | 18 | 10 | 16 | ATLS-CC-2.50x18 |
2.50 | 24 | 10 | 16 | ATLS-CC-2.50x24 |
2.50 | 28 | 10 | 16 | ATLS-CC-2.50x28 |
2.50 | 32 | 10 | 16 | ATLS-CC-2.50x32 |
2.50 | 38 | 10 | 16 | ATLS-CC-2.50x38 |
2.75 | 8 | 9 | 14 | ATLS-CC-2.75x08 |
2.75 | 12 | 9 | 14 | ATLS-CC-2.75x12 |
2.75 | 15 | 9 | 14 | ATLS-CC-2.75x15 |
2.75 | 18 | 10 | 16 | ATLS-CC-2.75x18 |
2.75 | 24 | 10 | 16 | ATLS-CC-2.75x24 |
2.75 | 28 | 10 | 16 | ATLS-CC-2.75x28 |
2.75 | 32 | 10 | 16 | ATLS-CC-2.75x32 |
2.75 | 38 | 10 | 16 | ATLS-CC-2.75x38 |
3.00 | 8 | 9 | 14 | ATLS-CC-3.00x08 |
3.00 | 12 | 9 | 14 | ATLS-CC-3.00x12 |
3.00 | 15 | 9 | 14 | ATLS-CC-3.00x15 |
3.00 | 18 | 10 | 16 | ATLS-CC-3.00x18 |
3.00 | 24 | 10 | 16 | ATLS-CC-3.00x24 |
3.00 | 28 | 10 | 16 | ATLS-CC-3.00x28 |
3.00 | 32 | 10 | 16 | ATLS-CC-3.00x32 |
3.00 | 38 | 10 | 16 | ATLS-CC-3.00x38 |
3.25 | 12 | 9 | 14 | ATLS-CC-3.25x12 |
3.25 | 15 | 9 | 14 | ATLS-CC-3.25x15 |
3.25 | 18 | 10 | 16 | ATLS-CC-3.25x18 |
3.25 | 24 | 10 | 16 | ATLS-CC-3.25x24 |
3.25 | 28 | 10 | 16 | ATLS-CC-3.25x28 |
3.25 | 32 | 10 | 16 | ATLS-CC-3.25x32 |
3.25 | 38 | 10 | 16 | ATLS-CC-3.25x38 |
3.50 | 8 | 9 | 14 | ATLS-CC-3.50x08 |
3.50 | 12 | 9 | 14 | ATLS-CC-3.50x12 |
3.50 | 15 | 9 | 14 | ATLS-CC-3.50x15 |
3.50 | 18 | 10 | 16 | ATLS-CC-3.50x18 |
3.50 | 24 | 10 | 16 | ATLS-CC-3.50x24 |
3.50 | 28 | 10 | 16 | ATLS-CC-3.50x28 |
3.50 | 32 | 10 | 16 | ATLS-CC-3.50x32 |
3.50 | 38 | 10 | 16 | ATLS-CC-3.50x38 |
4.00 | 8 | 9 | 14 | ATLS-CC-4.00x08 |
4.00 | 12 | 9 | 14 | ATLS-CC-4.00x12 |
4.00 | 15 | 9 | 14 | ATLS-CC-4.00x15 |
4.00 | 18 | 10 | 16 | ATLS-CC-4.00x18 |
4.00 | 24 | 10 | 16 | ATLS-CC-4.00x24 |
4.00 | 28 | 10 | 16 | ATLS-CC-4.00x28 |
4.00 | 32 | 10 | 16 | ATLS-CC-4.00x32 |
4.00 | 38 | 10 | 16 | ATLS-CC-4.00x38 |
Relaterede varer
-
Peta Sternal Closure Plate
Læs mereA titanium eller legering brystbenspladesystem, der giver stiv fiksering efter midtlinje sternotomi, hvilket forbedrer brystbensstabilitet og reducere risikoen for infektion eller dehiscens efter hjertekirurgi.
-
InWIRE 0,014" & 0,018" CTO-styretråd
Læs mereEn række højtydende udbud af guidewires holdbar nitinol eller Rustfri kerner, hydrofile belægninger og flere spidsformer til krydsning af forkalket eller kompleks koronare og perifere læsioner.
-
Extender Lægemiddeludvidende PTA-ballonkateter
Læs mereExtender Lægemiddeludvidende PTA-ballonkateter; A lægemiddelbelagt ballon til perifer transluminal angioplastik (PTA), frigørelse af antiproliferativ midler til at mindske restenose i femorale eller popliteale arterier.
-
Atlas Peripheral Stent System
Læs mereA robust peripheral stent platform designed for femoral, iliaceller popliteal lesions, ensuring adequate radial støtte og low restenosis rates in PAD interventions.